| Q39241495 | Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer |
| Q37426349 | Chemotherapy for patients with poor prognosis germ cell tumors |
| Q24545469 | EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury |
| Q30313117 | Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity |
| Q38602699 | Emerging Therapeutic Targets for Male Germ Cell Tumors |
| Q37721103 | Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 in Cancer Development and Tumor Angiogenesis. |
| Q41885351 | Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate |
| Q36169443 | Microinvasive germ cell tumor of the testis |
| Q89699776 | Multipotency of mouse trophoblast stem cells |
| Q34544846 | Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial |
| Q39692519 | Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours |
| Q45957719 | Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors. |
| Q28565180 | Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy |
| Q37350092 | Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumors. |
| Q61455764 | VEGF overexpression is associated with optic nerve involvement and differentiation of retinoblastoma: A PRISMA-compliant meta-analysis |
| Q84131239 | [Urine-based markers of angiogenesis in bladder cancer] |